{"award_age":64.0,"bio_image":"full\/acc8de92b882aee1cb36ba15ce4ea168767229fd.jpg","category":"Physiology or Medicine","country":"United Kingdom","date_of_birth":"1924-06-14T00:00:00.000Z","date_of_death":"2010-03-22T00:00:00.000Z","gender":"male","image_urls":["http:\/\/upload.wikimedia.org\/wikipedia\/en\/thumb\/f\/f8\/James_Black.jpeg\/220px-James_Black.jpeg"],"link":"http:\/\/en.wikipedia.org\/wiki\/James_W._Black","mini_bio":"<p><b>Sir James Whyte Black<\/b> <a href=\"http:\/\/en.wikipedia.org\/wiki\/Order_of_Merit\" title=\"Order of Merit\">OM<\/a> <a href=\"http:\/\/en.wikipedia.org\/wiki\/Royal_Society\" title=\"Royal Society\">FRS<\/a> <a href=\"http:\/\/en.wikipedia.org\/wiki\/Royal_Society_of_Edinburgh\" title=\"Royal Society of Edinburgh\">FRSE<\/a> <a href=\"http:\/\/en.wikipedia.org\/wiki\/Royal_College_of_Physicians\" title=\"Royal College of Physicians\">FRCP<\/a> (14 June 1924 \u2013 22 March 2010<sup id=\"cite_ref-ObitSTV_1-0\" class=\"reference\"><a href=\"http:\/\/en.wikipedia.org\/wiki\/James_W._Black#cite_note-ObitSTV-1\"><span>[<\/span>1<span>]<\/span><\/a><\/sup>) was a Scottish <a href=\"http:\/\/en.wikipedia.org\/wiki\/Pharmacology\" title=\"Pharmacology\">pharmacologist<\/a>. Black established the physiology department at the <a href=\"http:\/\/en.wikipedia.org\/wiki\/University_of_Glasgow\" title=\"University of Glasgow\">University of Glasgow<\/a>, where he became interested in the effects of <a href=\"http:\/\/en.wikipedia.org\/wiki\/Adrenaline\" title=\"Adrenaline\" class=\"mw-redirect\">adrenaline<\/a> on the <a href=\"http:\/\/en.wikipedia.org\/wiki\/Human_heart\" title=\"Human heart\" class=\"mw-redirect\">human heart<\/a>. He went to work for <a href=\"http:\/\/en.wikipedia.org\/wiki\/Imperial_Chemical_Industries\" title=\"Imperial Chemical Industries\">ICI Pharmaceuticals<\/a> in 1958 and, while there, developed <a href=\"http:\/\/en.wikipedia.org\/wiki\/Propranolol\" title=\"Propranolol\">propranolol<\/a>, a <a href=\"http:\/\/en.wikipedia.org\/wiki\/Beta_blocker\" title=\"Beta blocker\">beta blocker<\/a> used for the treatment of heart disease.<sup id=\"cite_ref-Black_JW.2C_Crowther_AF.2C_Shanks_RG.2C_Smith_LH.2C_Dornhorst_AC_1964_1080.E2.80.931081_2-0\" class=\"reference\"><a href=\"http:\/\/en.wikipedia.org\/wiki\/James_W._Black#cite_note-Black_JW.2C_Crowther_AF.2C_Shanks_RG.2C_Smith_LH.2C_Dornhorst_AC_1964_1080.E2.80.931081-2\"><span>[<\/span>2<span>]<\/span><\/a><\/sup> Black was also responsible for the development of <a href=\"http:\/\/en.wikipedia.org\/wiki\/Cimetidine\" title=\"Cimetidine\">cimetidine<\/a>, a H2 receptor antagonist, a drug used in a similar manner to treat <a href=\"http:\/\/en.wikipedia.org\/wiki\/Stomach_ulcers\" title=\"Stomach ulcers\" class=\"mw-redirect\">stomach ulcers<\/a>. He was awarded the <a href=\"http:\/\/en.wikipedia.org\/wiki\/Nobel_Prize_in_Physiology_or_Medicine\" title=\"Nobel Prize in Physiology or Medicine\">Nobel Prize for Medicine<\/a> in 1988 for work leading to the development of propranolol and cimetidine.<sup id=\"cite_ref-nobel_3-0\" class=\"reference\"><a href=\"http:\/\/en.wikipedia.org\/wiki\/James_W._Black#cite_note-nobel-3\"><span>[<\/span>3<span>]<\/span><\/a><\/sup><\/p>","name":"James W. Black","place_of_birth":"Uddingston, Lanarkshire, Scotland","place_of_death":"London","text":"James W. Black , Physiology or Medicine, 1988","year":1988.0}